Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03072849 · ClinicalTrials.gov registry record
Early Detection and Management of Bronchiolitis Obliterans Syndrome Following Pediatric Hematopoietic Stem Cell Transplantation
A clinical trial, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- 23
- Enrollment target
NCT03072849 is a clinical trial that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 23 participants.
The verdict
NCT03072849 has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
This study aims to determine whether or not early spirometric detection and management of obstructive lung disease with combined fluticasone/azithromycin/montelukast therapy (FAM) can attenuate declining lung function, prevent the development of bronchiolitis obliterans, and improve patient outcomes following hematopoietic stem cell transplant.
Interventions
- PROCEDURE Pulmonary function testing
- DRUG FAM Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2015-04 |
| Est. Completion | 2020-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03072849
The ClinicalTrials.gov registry entry for NCT03072849 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pulmonary function testing is the first listed.
NCT03072849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03072849 about?
NCT03072849 is a clinical study titled "Early Detection and Management of Bronchiolitis Obliterans Syndrome Following Pediatric Hematopoietic Stem Cell Transplantation". This study aims to determine whether or not early spirometric detection and management of obstructive lung disease with combined fluticasone/azithromycin/montelukast therapy (FAM) can attenuate declining lung function, prevent the development of bronchiolitis obliterans, and improve patient outcomes...
What is the current status of trial NCT03072849?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2015-04. Estimated completion is 2020-09-01.
What interventions are being tested in trial NCT03072849?
The interventions under investigation include: Pulmonary function testing (PROCEDURE), FAM Therapy (DRUG).
Who is sponsoring clinical trial NCT03072849?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.